MedRhythms, a company engaged in developing prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, announced today the closing of a $25 million Series B financing round co-led by Morningside Ventures and Advantage Capital, with participation from existing investor Werth Family Investment Associates. The company has raised a total of $34 million in gross proceeds from private financings since inception. Read more.
Related Posts
MSouth Partners with Medix Staffing Solutions
Medix operates 21 offices across the U.S. with operations in 44 states.
October 17, 2022
Maternal Health Platform Mae Launches with $1.3M
Mae’s delivery model is designed to drive health equity and positive outcomes for Black expectant mothers and their babies.
September 8, 2021
Trinity Health Invests $1M in Xealth
Trinity is one of 15 health system investors for the company.
October 19, 2021
Moxe Health Scores $30M
Piper Sandler Merchant Banking and Vensana Capital led the round.
June 2, 2022